Přehled o publikaci
2025
Anti-biofilm and anti-quorum sensing activities of galloylquinic acid against clinical isolates of multidrug-resistant Pseudomonas aeruginosa in open wound infection: in vitro and in vivo efficacy studies
AL-MADDBOLY, Lamiaa A., Mohamed Abd EL-SALAM, Jairo K. BASTOS, Eiman A. HASBY, Ivan KUSHKEVYCH et. al.Basic information
Original name
Anti-biofilm and anti-quorum sensing activities of galloylquinic acid against clinical isolates of multidrug-resistant Pseudomonas aeruginosa in open wound infection: in vitro and in vivo efficacy studies
Authors
AL-MADDBOLY, Lamiaa A., Mohamed Abd EL-SALAM, Jairo K. BASTOS, Eiman A. HASBY, Ivan KUSHKEVYCH and Rasha M. EL-MORSI
Edition
BMC Microbiology, London, BioMed Central, 2025, 1471-2180
Other information
Language
English
Type of outcome
Article in a journal
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
is not subject to a state or trade secret
References:
Organization
Přírodovědecká fakulta – Repository – Repository
UT WoS
001464224500005
EID Scopus
2-s2.0-105003001842
Keywords in English
Antibacterial; Pseudomonas aeruginosa; Anti-biofilm; Galloylquinic acid compounds
Changed: 6/6/2025 00:50, RNDr. Daniel Jakubík
Abstract
V originále
lt; 0.05) reduced rhamnolipid, pyocyanin, and the swarming motility of the organism which play a vital role in the biofilm formation. GQAs downregulated 89% of the quorum-sensing genes (lasI and lasR, pqsA and pqsR) involved in the biofilm formation. Conclusion: GQAs demonstrate significant promise as novel and potent antibiofilm and antivirulence agents against clinical isolates of MDR P. aeruginosa, with substantial potential to enhance wound healing in biofilm-associated infections. This promising antibacterial action positions GQAs as a superior alternative for the treatment of biofilm-associated wound infections, with substantial potential to improve wound healing and mitigate the impact of persistent bacterial infections. Clinical trial number: not applicable.